AMERICAN SHARED HOSPITAL SERVICES Financing Cash Flow
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Financing Cash Flow of -$1.24 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- AMERICAN SHARED HOSPITAL SERVICES net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$640.00K, a 130.29% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$597.00K, a 134.55% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$2.91M, a 325.99% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$3.96M.
- AMERICAN SHARED HOSPITAL SERVICES net cash provided by (used in) financing activities for fiscal 2025 was -$3.03M, a 168.72% decline from fiscal 2024.
- AMERICAN SHARED HOSPITAL SERVICES net cash provided by (used in) financing activities for fiscal 2024 was $4.41M, a 130.63% increase from fiscal 2023.
- AMERICAN SHARED HOSPITAL SERVICES net cash provided by (used in) financing activities for fiscal 2023 was $1.91M.
- AMERICAN SHARED HOSPITAL SERVICES net cash provided by (used in) financing activities for fiscal 2022 was -$2.66M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$640.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$1.24M 10-Q · filed 2026-08-13 | -$4.15M derived: sum of 3 quarters · filed 2026-08-13 | -$8.11M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | -$597.00K 10-Q · filed 2026-05-14 | -$3.51M derived: sum of 2 quarters · filed 2026-05-14 | -$7.46M derived: sum of 3 quarters · filed 2026-05-14 | -$5.35M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | -$2.91M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-31 | -$6.87M derived: sum of 2 quarters · filed 2026-03-31 | -$4.75M derived: sum of 3 quarters · filed 2026-08-13 | -$3.03M 10-K · filed 2026-03-31 | |||
| 2025-09-30 | -$3.96M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-01-16 | -$1.84M derived: sum of 2 quarters · filed 2026-08-13 | -$114.00K 10-Q/A · filed 2026-01-16 | $1.18M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | $2.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $3.84M 10-Q · filed 2026-08-13 | $5.13M derived: sum of 3 quarters · filed 2026-08-13 | $4.95M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | $1.73M 10-Q · filed 2026-05-14 | $3.02M derived: sum of 2 quarters · filed 2026-05-14 | $2.84M derived: sum of 3 quarters · filed 2026-05-14 | $3.85M derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | $1.29M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-31 | $1.11M derived: sum of 2 quarters · filed 2026-03-31 | $2.12M derived: sum of 3 quarters · filed 2026-03-31 | $4.41M 10-K · filed 2026-03-31 | |||
| 2024-09-30 | -$177.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-01-16 | $834.00K derived: sum of 2 quarters · filed 2026-01-16 | $3.12M 10-Q/A · filed 2026-01-16 | $5.43M derived: sum of 4 quarters · filed 2026-01-16 | |||
| 2024-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $3.29M 10-Q · filed 2025-08-13 | $5.60M derived: sum of 3 quarters · filed 2025-08-13 | $6.51M derived: sum of 4 quarters · filed 2025-08-13 | |||
| 2024-03-31 | $2.28M 10-Q · filed 2025-05-15 | $4.59M derived: sum of 2 quarters · filed 2025-05-15 | $5.50M derived: sum of 3 quarters · filed 2025-05-15 | $5.00M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $3.22M derived: sum of 2 quarters · filed 2025-04-04 | $2.71M derived: sum of 3 quarters · filed 2025-04-04 | $1.91M 10-K · filed 2025-04-04 | |||
| 2023-09-30 | $912.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $404.00K derived: sum of 2 quarters · filed 2024-11-14 | -$400.00K 10-Q · filed 2024-11-14 | -$1.16M derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | -$508.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$1.31M 10-Q · filed 2024-08-14 | -$2.07M derived: sum of 3 quarters · filed 2024-08-14 | -$3.68M derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | -$804.00K 10-Q · filed 2024-05-15 | -$1.56M derived: sum of 2 quarters · filed 2024-05-15 | -$3.17M derived: sum of 3 quarters · filed 2024-05-15 | -$3.41M derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | -$757.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$2.37M derived: sum of 2 quarters · filed 2024-04-01 | -$2.60M derived: sum of 3 quarters · filed 2024-04-01 | -$2.66M 10-K · filed 2024-04-01 | |||
| 2022-09-30 | -$1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$1.84M derived: sum of 2 quarters · filed 2023-11-14 | -$1.90M 10-Q · filed 2023-11-14 | -$2.60M derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | -$237.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$292.00K 10-Q · filed 2023-08-14 | -$994.00K derived: sum of 3 quarters · filed 2023-08-14 | -$1.46M derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | -$55.00K 10-Q · filed 2023-05-12 | -$757.00K derived: sum of 2 quarters · filed 2023-05-12 | -$1.22M derived: sum of 3 quarters · filed 2023-05-12 | $320.00K derived: sum of 4 quarters · filed 2023-05-12 | |||
| 2021-12-31 | -$702.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$1.17M derived: sum of 2 quarters · filed 2023-03-31 | $375.00K derived: sum of 3 quarters · filed 2023-03-31 | -$655.00K 10-K · filed 2023-03-31 | |||
| 2021-09-30 | -$467.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.08M derived: sum of 2 quarters · filed 2022-11-10 | $47.00K 10-Q · filed 2022-11-10 | -$1.17M derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | $1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $514.00K 10-Q · filed 2022-08-15 | -$705.00K derived: sum of 3 quarters · filed 2022-08-15 | -$1.90M derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-03-31 | -$1.03M 10-Q · filed 2022-05-12 | -$2.25M derived: sum of 2 quarters · filed 2022-05-12 | -$3.44M derived: sum of 3 quarters · filed 2022-05-12 | -$3.89M derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$2.41M derived: sum of 2 quarters · filed 2022-03-30 | -$2.86M derived: sum of 3 quarters · filed 2022-03-30 | -$4.81M 10-K · filed 2022-03-30 | |||
| 2020-09-30 | -$1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$1.64M derived: sum of 2 quarters · filed 2021-11-10 | -$3.59M 10-Q · filed 2021-11-10 | -$5.12M derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | -$451.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$2.40M 10-Q · filed 2021-08-12 | -$3.93M derived: sum of 3 quarters · filed 2021-08-12 | -$6.31M derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | -$1.95M 10-Q · filed 2021-05-13 | -$3.48M derived: sum of 2 quarters · filed 2021-05-13 | -$5.86M derived: sum of 3 quarters · filed 2021-05-13 | -$7.44M derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | -$1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-06 | -$3.91M derived: sum of 2 quarters · filed 2021-04-06 | -$5.49M derived: sum of 3 quarters · filed 2021-04-06 | -$7.07M 10-K · filed 2021-04-06 | |||
| 2019-09-30 | -$2.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$3.96M derived: sum of 2 quarters · filed 2020-11-13 | -$5.54M 10-Q · filed 2020-11-13 | -$7.44M derived: sum of 4 quarters · filed 2020-11-13 | |||
| 2019-06-30 | -$1.58M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2020-08-14 | -$3.16M 10-Q · filed 2020-08-14 | -$5.06M derived: sum of 3 quarters · filed 2020-08-14 | -$6.99M derived: sum of 4 quarters · filed 2020-08-14 | |||
| 2019-03-31 | -$1.58M 10-Q/A · filed 2020-06-11 | -$3.48M derived: sum of 2 quarters · filed 2020-06-11 | -$5.41M derived: sum of 3 quarters · filed 2020-06-11 | -$7.31M derived: sum of 4 quarters · filed 2020-06-11 | |||
| 2018-12-31 | -$1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | -$3.83M derived: sum of 2 quarters · filed 2020-04-03 | -$5.72M derived: sum of 3 quarters · filed 2020-04-03 | -$7.25M 10-K · filed 2020-04-03 | |||
| 2018-09-30 | -$1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$3.83M derived: sum of 2 quarters · filed 2019-11-07 | -$5.35M 10-Q · filed 2019-11-07 | -$7.35M derived: sum of 4 quarters · filed 2020-04-03 | |||
| 2018-06-30 | -$1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$3.42M 10-Q · filed 2019-08-13 | -$5.42M derived: sum of 3 quarters · filed 2020-04-03 | -$7.26M derived: sum of 4 quarters · filed 2020-04-03 | |||
| 2018-03-31 | -$1.52M 10-Q · filed 2019-05-13 | -$3.52M derived: sum of 2 quarters · filed 2020-04-03 | -$5.36M derived: sum of 3 quarters · filed 2020-04-03 | -$7.34M derived: sum of 4 quarters · filed 2020-04-03 | |||
| 2017-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | -$3.84M derived: sum of 2 quarters · filed 2020-04-03 | -$5.82M derived: sum of 3 quarters · filed 2020-04-03 | -$7.82M 10-K · filed 2020-04-03 | -$7.92M 10-K · filed 2018-03-28 | ||
| 2017-09-30 | -$1.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$3.82M derived: sum of 2 quarters · filed 2018-11-09 | -$5.82M 10-Q · filed 2018-11-09 | -$5.92M 10-Q · filed 2017-11-13 | -$7.29M derived: sum of 4 quarters · filed 2019-03-29 | ||
| 2017-06-30 | -$1.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$3.98M 10-Q · filed 2018-08-09 | -$5.45M derived: sum of 3 quarters · filed 2019-03-29 | ||||
| 2017-03-31 | -$2.00M 10-Q · filed 2018-05-10 | -$3.47M derived: sum of 2 quarters · filed 2019-03-29 | |||||
| 2016-12-31 | -$1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$6.47M 10-K · filed 2019-03-29 | -$6.67M 10-K · filed 2018-03-28 | ||||
| 2016-09-30 | -$5.01M 10-Q · filed 2017-11-13 | ||||||
| 2015-12-31 | -$6.49M 10-K · filed 2018-03-28 | ||||||
| 2013-12-31 | -$3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$5.40M derived: sum of 2 quarters · filed 2014-03-31 | -$4.00M derived: sum of 3 quarters · filed 2014-03-31 | -$6.02M 10-K · filed 2014-03-31 | |||
| 2013-09-30 | -$2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$659.00K derived: sum of 2 quarters · filed 2013-11-14 | -$2.68M 10-Q · filed 2013-11-14 | -$1.76M derived: sum of 4 quarters · filed 2014-03-31 | |||
| 2013-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$618.00K 10-Q · filed 2013-08-14 | $306.00K derived: sum of 3 quarters · filed 2014-03-31 | -$1.19M derived: sum of 4 quarters · filed 2014-03-31 | |||
| 2013-03-31 | -$2.02M 10-Q · filed 2013-05-15 | -$1.10M derived: sum of 2 quarters · filed 2014-03-31 | -$2.60M derived: sum of 3 quarters · filed 2014-03-31 | -$4.15M derived: sum of 4 quarters · filed 2014-03-31 | |||
| 2012-12-31 | $924.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$575.00K derived: sum of 2 quarters · filed 2014-03-31 | -$2.13M derived: sum of 3 quarters · filed 2014-03-31 | -$1.22M 10-K · filed 2014-03-31 | |||
| 2012-09-30 | -$1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$3.05M derived: sum of 2 quarters · filed 2013-11-14 | -$2.15M 10-Q · filed 2013-11-14 | $3.03M derived: sum of 4 quarters · filed 2014-03-31 | |||
| 2012-06-30 | -$1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$647.00K 10-Q · filed 2013-08-14 | $4.53M derived: sum of 3 quarters · filed 2014-03-31 | $3.88M derived: sum of 4 quarters · filed 2014-03-31 | |||
| 2012-03-31 | $903.00K 10-Q · filed 2013-05-15 | $6.08M derived: sum of 2 quarters · filed 2014-03-31 | $5.43M derived: sum of 3 quarters · filed 2014-03-31 | $3.39M derived: sum of 4 quarters · filed 2014-03-31 | |||
| 2011-12-31 | $5.17M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $4.52M derived: sum of 2 quarters · filed 2014-03-31 | $2.48M derived: sum of 3 quarters · filed 2014-03-31 | -$29.00K 10-K · filed 2014-03-31 | -$1.54M 10-K · filed 2012-03-30 | ||
| 2011-09-30 | -$651.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | -$2.69M derived: sum of 2 quarters · filed 2012-11-14 | -$5.20M 10-Q · filed 2012-11-14 | -$4.11M 10-Q · filed 2011-11-14 | -$7.45M derived: sum of 4 quarters · filed 2013-03-29 | ||
| 2011-06-30 | -$2.04M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-07 | -$4.55M 10-Q/A · filed 2012-09-07 | -$3.58M 10-Q · filed 2011-08-15 | -$6.80M derived: sum of 3 quarters · filed 2013-03-29 | -$7.98M derived: sum of 4 quarters · filed 2013-03-29 | ||
| 2011-03-31 | -$2.51M 10-Q · filed 2012-05-15 | -$4.76M derived: sum of 2 quarters · filed 2013-03-29 | -$5.94M derived: sum of 3 quarters · filed 2013-03-29 | ||||
| 2010-12-31 | -$2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | -$3.43M derived: sum of 2 quarters · filed 2013-03-29 | -$6.26M 10-K · filed 2013-03-29 | ||||
| 2010-09-30 | -$1.18M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | -$4.02M 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | -$2.84M 10-Q/A · filed 2011-10-24 | ||||||
| 2009-12-31 | -$7.01M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |